RMED's Electrophysiology Division Expands International Distribution
Portfolio Pulse from Happy Mohamed
Ra Medical Systems, Inc. (NYSE:RMED) is expanding its international distribution in anticipation of the receipt of the CE Mark for its new device, LockeT, expected in Q3 2023. The company has entered into a distribution agreement with Medilynq for the Middle East and is working with Bioline in Spain. RMED is also in the process of working toward agreements in Mexico, Peru, Chile, Brazil, Australia, Hong Kong, Thailand, and Malaysia.
July 03, 2023 | 12:03 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Ra Medical Systems is expanding its international distribution, which could potentially increase its market reach and revenue. The expected receipt of the CE Mark for its new device, LockeT, in Q3 2023 could further boost its international presence.
The expansion of international distribution and the expected receipt of the CE Mark for its new device, LockeT, could potentially increase Ra Medical Systems' market reach and revenue. This could have a positive impact on the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100